Revita T2Di Study

The purpose of this research study is to learn more about the use of the Fractyl Revita System for the treatment of Type 2 diabetes for patients who are on insulin therapy. Researchers are testing a new method, Duodenal mucosal resurfacing (DMR), which is a novel, minimally invasive, upper endoscopic procedure involving heating of the duodenal mucosa as a form of treatment for patients with type 2 Diabetes. You will be randomized to either Sham or DMR Procedure, with the opportunity to cross-over to the DMR procedure at the completion of the study. The study will last 2 years, with a total of 16 visits compensating at $100 per visit.